BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orphan Therapeutics, LLC 

3 Werner Way, Suite 300

Lebanon  New Jersey  08833  U.S.A.
Phone: 908-849-4805 Fax: 908-849-4806


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Ikaria Holdings: FDA Accepts Final Section of NDA Filing for LUCASSIN(R) 6/12/2009 8:38:00 AM    More...
Ikaria Inc. Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics, LLC 9/2/2008 10:08:26 AM    More...
Orphan Therapeutics, LLC Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1 5/28/2008 10:58:52 AM    More...
PDL BioPharma, Inc. (PDLI) And Orphan Therapeutics, LLC End Collaboration Agreement For Terlipressin 12/19/2006 1:02:07 PM    More...
Orphan Therapeutics, LLC Announces Rolling NDA Submission For LUCASSIN(TM) (terlipressin) To Treat Type 1 Hepatorenal Syndrome 12/18/2006 1:39:00 PM    More...
Jazz Pharmaceuticals, Inc. To Buy Orphan Medical, Inc. (ORPH) For About $122.6 Million In Cash 10/19/2005 5:13:08 PM    More...
Protein Design Labs, Inc. (PDLI) And Orphan Therapeutics, LLC Report Fast Track Designation For Terlipressin In Type 1 Hepatorenal Syndrome 10/19/2005 5:13:02 PM    More...